REFERENCES
- Segal S. A new delivery system for contraceptive steroids. Am J Obstet Gynecol 1987;157:1090
- Diaz S, Pavez M, Miranda P, et al. Long-term follow-up of women treated with Norplant implants. Contraception 1987;35:551
- Frank ML, Poindexter AN, Johnson ML, et al. Charac- teristics and attitudes of early contraceptive implant acceptors in Texas. Fam Plann Perspect 1992;24:208
- Hillard P. Family planning in the teen population. Curr Opin Obstet Gynecol 1993;5:798
- Cardamakis E, Deligeoroglou E, Salakos N, et al. Com- parison between tenoxicam (prostaglandin synthetase inhibitor) and lyne-strenol plus ethinylestradiol in the treatment of established menorrhagia in adolescents. In Recent Developments on Pediatric Adolescent Gynecology and Endocrinology [Abstr]. 1993: 67
- Shoupe D, Mishell D. Norplant: subdermal implant system for long-term contraception. Am J Obstet Gynecol 1989;160:1286
- Bardin CW, Sivin I. Norplant contraceptive implants: a new contraceptive for women. IPPF Med Bull 1985; 19: 2
- Croxatto H. Report to the ICCR. New York: Population Council, 1980
- Croxatto HD, Diaz S, Pavez M, et al. Histopathology of the endometrium during continuous use of levonor- gestrel. In Zatuchni GI, Goldsmith A, Shelton JD, Sciarra JJ, eds. Long-acting Contraceptive Delivery System. Philadelphia: Harper and Row, 1984: 290–5
- Moore DE, Roy S, Stanczyk FZ, et al. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women with d-norgestrel subdermal polysiloxane capsules for contraception. Contraception 1978;17:315
- Liskin I, Blackburn R, Ghgani R. Hormonal contra- ception: new long-acting methods. In Population Infor- mation Program. Series K. Baltimore: The Johns Hopkins University, 1987
- Greatsas G. Sexuality: sexual activity and contraception during adolescence. Curr Opin Obstet Gynecol 1993; 5: 774
- Sivin I, Diaz S, Holma P, et al. A four-year clinical study of Norplant implants. Stud Fam Plann 1983;1:184
- Nilsson CG, Holma P. Menstrual blood loss with contraceptive subdermal levonorgestrel implants. Fertil Steril 1981;35:304
- Bardin CW, Sivin I, Nash. Norplant Contraceptive Implants. New York: Population Council, 1987
- Berenson AB, Wiemann CM. Use of levonorgestrel implants versus oral contraceptives in adolescence: a case control study. Am J Obstet Gynecol 1995;172:128
- Alvarez-Sanchez F, Brache V, et al. Hormonal treat- ment for bleeding irregularities in users of Norplant implant. Am J Obstet Gynecol 1996;174:919
- Fraser JS, Tiïtinen A, Sivin I, et al. NorplantÒ consensus statement and background review. Contraception 57: 1
- Roy S, Mishell DR Jr, Robertson DN, et al. Long-term reversible contraception with levonorgestrel-releasing silastic rods. Am J Obstet Gynecol 1984;148:1006
- Lopez G, Rodriguez A, Rengifo I, et al. Two-year prospective study in Colombia of Norplant implant. Obstet Gynecol 1986;68:204
- Shaaban MM, Salah M, Zarrour A, et al. A prospective study of Norplant implants and the TCu 380 Ag IUD in Asia, Egypt. Stud Fam Plann 1987;14:163
- Sivin I. Clinical effects of Norplant subdermal implants for contraception. In Mishell DR Jr, ed. Advances in Human Fertility and Reproductive Endocrinology. New York: Raven Press, 1983;2:89
- Sivin I, Sanchez FA, Diaz S. Three-year experience with Norplant subdermal contraception. Fertil Steril 1983;39:799
- Diaz S, Pavez M, Miranda P, et al. Long term follow up of women treated with Norplant implants. Contraception 1987;35:569
- Creatsas G, Adamopoulos P, Eleftheriou N, et al. Clinical and metabolic effects of the monophasic gestodene/ethinylestradiol pill for contraception during adolescence. Adolesc Pediatr Gynecol 1991;4:76
- Cullins VE, Blumenthal PD, Remsburg RE. Pre- liminary experience with Norplant in an inner city population. Contraception 1993;47:193